MarketInOut Stock Screener Log In | Sign Up

NIOX Group Plc

LSE • Healthcare • Medical Devices • Quote as of 10/30/2026
NIOX Group Plc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeLSE
Market Capitalization276.45 mln
Float307 mln
Earnings Date03/23/2027

EPS

2.00
Stretched

P / E

33.80
Overvalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-3.02
Reliable

1-Year Forecast

82.40
Attractive

Relative Strength

52 / 100
In line with market

Business Description

NIOX Group Plc, based in Oxford, United Kingdom, develops and sells medical tools that help doctors diagnose and manage respiratory conditions like asthma and COPD. Its main product, NIOX VERO, is a compact handheld device that measures a specific marker in a patient's breath to assess airway inflammation quickly and without any invasive procedures. Originally founded in 2006 under the name Circassia Group Plc, the company rebranded to its current name in September 2022.

Key Fundamentals

EPS2.00
P/E33.80
ROE10.28
RPS0.11
ROIC12.28
ROA9.53
Interest Cover52.00
EBITDA, mln15.80
EV / EBITDA16.37
EV / EBIT22.49
Revenue, mln47.50
EV / Revenue5.45

Quote Details

Last 67.60
Change -1.4 (-2.03%)
Open 69.80
Volume 530,164
Turnover 35,839,084
Average Volume 1,112,956

Financial Ratios

Pre-Tax Profit Margin24
Leverage Ratio1.11
Current Ratio4.60
Price / Book4.39
Price / Tangible Book6.90
Price / Cash Flow22.52
Price / Free Cash Flow23.79
Debt / Equity0.01
Price / Sales6.22

Financial Strength

Altman Z-Score21.27
Piotroski F-Score 8 / 9
Beneish M-Score-3.02
Price to Intrinsic Value4.60
Price to Graham Number3.63
1-Year Target Price82.40

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.74% 23 / 100   
1 Month 2.42% 74 / 100   
2 Months 4.64% 80 / 100   
6 Months 5.76% 65 / 100   
1 Year 0.84% 36 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog